Home LiteratureArticle Details
PMID: 9658127 Published · ppublish English Journal Article

Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression.

Journal of virology ·Vol. 72 ·No. 8 ·1998-08-00 ·Pages 6785-95

Baumert TF, Marrone A, Vergalla J, Liang TJ

Abstract

Functional analysis of naturally occurring hepatitis B virus (HBV) mutations is crucial in understanding their impact on disease. We have recently identified two mutations in the HBV core promoter of an HBV strain associated with fulminant hepatitis leading to highly (15-fold) enhanced replication as a result of increased viral encapsidation of pregenomic RNA into the core particles (T. F. Baumert et al., J. Clin. Invest. 98:2268-2276, 1996). Functional studies in an encapsidation assay had demonstrated that the increase in encapsidation was largely independent of pregenomic RNA transcription. In this study, we define the molecular mechanism whereby the two core promoter mutations (C to T at nucleotide [nt] 1768 and T to A at nt 1770) result in enhanced viral encapsidation and replication. The effect of these mutations leading to increased encapsidation is mediated through enhanced core protein synthesis (15-fold) by the mutant virus. The marked increase in core protein synthesis is largely a result of posttranscriptional or translational effect of the mutations because the mutations resulted in only a twofold increase in pregenomic RNA transcription. In addition, this effect appears to be selective for core expression since reverse transcriptase-polymerase expression was increased only twofold. trans-complementation analyses of HBV replication demonstrated that enhanced replication occurred only when the mutations were provided together with the core protein in trans, confirming the functional association of the core promoter mutations and core protein expression. In addition, the effect of the mutations appears to be quantitatively dependent on the strain background to which the mutations were introduced. Our study suggests that the HBV core promoter regulates core protein expression at both transcriptional and posttranscriptional levels.

MeSH Terms
Gene Expression Regulation, Viral Genes, Viral Hepatitis B Core Antigens/genetics Hepatitis B virus/genetics,physiology Humans Mutagenesis Mutation Open Reading Frames Promoter Regions, Genetic Protein Precursors/metabolism RNA-Directed DNA Polymerase/biosynthesis Tumor Cells, Cultured Virus Replication
Chemicals
Hepatitis B Core Antigens Protein Precursors RNA-Directed DNA Polymerase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Baumert T F
Liver Diseases Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Marrone A
Vergalla J
Liang T J
References (43)
43 references, click to expand
  1. A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products.
    Mol Cell Biol. 1993 Dec;13(12):7476-86 PMID: 8246965
  2. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.
    Cell. 1993 Nov 19;75(4):653-60 PMID: 8242741
  3. Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis.
    J Virol. 1994 Sep;68(9):5579-87 PMID: 7520092
  4. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis.
    Ann Intern Med. 1995 Feb 15;122(4):241-8 PMID: 7825758
  5. Hepatitis B virus immunopathogenesis.
    Annu Rev Immunol. 1995;13:29-60 PMID: 7612225
  6. The mechanism of natural occurrence of two closely linked HBV precore predominant mutations.
    Virology. 1995 Aug 1;211(1):144-56 PMID: 7645207
  7. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells.
    RNA. 1995 Jul;1(5):453-65 PMID: 7489507
  8. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.
    Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1065-70 PMID: 8577715
  9. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation.
    Hepatology. 1996 Aug;24(2):300-6 PMID: 8690396
  10. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.
    J Virol. 1996 Sep;70(9):5845-51 PMID: 8709203
  11. A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix.
    Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8253-7 PMID: 8710856
  12. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication.
    J Clin Invest. 1996 Nov 15;98(10):2268-76 PMID: 8941643
  13. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.
    Virology. 1996 Dec 15;226(2):269-80 PMID: 8955047
  14. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.
    J Virol. 1996 Dec;70(12):8318-31 PMID: 8970951
  15. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter.
    J Virol. 1997 Feb;71(2):1058-71 PMID: 8995626
  16. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription.
    Nature. 1997 Jan 23;385(6614):357-61 PMID: 9002523
  17. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
    J Virol. 1997 Mar;71(3):2192-201 PMID: 9032353
  18. A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B.
    Hepatology. 1997 Jun;25(6):1507-15 PMID: 9185776
  19. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame.
    Virology. 1997 Jul 7;233(2):374-81 PMID: 9217060
  20. Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily.
    J Virol. 1997 Dec;71(12):9366-74 PMID: 9371596
  21. Tables for estimating sedimentation through linear concentration gradients of sucrose solution.
    Anal Biochem. 1967 Jul;20(1):114-49 PMID: 6034985
  22. Biochemical and biophysical properties of hepatitis B core particles derived from Dane particles and infected hepatocytes.
    Intervirology. 1977;8(6):336-50 PMID: 893038
  23. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.
    Nature. 1979 Oct 25;281(5733):646-50 PMID: 399327
  24. Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.
    Cell. 1982 Jun;29(2):403-15 PMID: 6180831
  25. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.
    Nucleic Acids Res. 1984 Jan 25;12(2):857-72 PMID: 6694911
  26. The hepatitis B virus.
    Nature. 1985 Oct 10-16;317(6037):489-95 PMID: 2995835
  27. Replication strategy of human hepatitis B virus.
    J Virol. 1987 Mar;61(3):904-11 PMID: 3806799
  28. The molecular biology of the hepatitis B viruses.
    Annu Rev Biochem. 1987;56:651-93 PMID: 3039907
  29. Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.
    Nature. 1990 Apr 5;344(6266):552-5 PMID: 1690862
  30. A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA.
    EMBO J. 1990 Oct;9(10):3389-96 PMID: 2209549
  31. Translational inactivation of RNA function: discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly.
    Cell. 1990 Dec 21;63(6):1357-63 PMID: 2261646
  32. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication.
    J Virol. 1991 Apr;65(4):1836-42 PMID: 2002544
  33. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.
    N Engl J Med. 1991 Jun 13;324(24):1705-9 PMID: 2034247
  34. Cap recap: the involvement of eIF-4F in regulating gene expression.
    Cell. 1992 Jan 24;68(2):177-180 PMID: 1733496
  35. Characterization of hepatitis B virus capsid particle assembly in Xenopus oocytes.
    J Virol. 1992 May;66(5):3086-92 PMID: 1560538
  36. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus.
    J Virol. 1992 Jul;66(7):4073-84 PMID: 1602534
  37. mRNAs containing extensive secondary structure in their 5' non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E.
    EMBO J. 1992 Nov;11(11):4153-8 PMID: 1396596
  38. A fraction of the mRNA 5' cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus.
    Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9612-6 PMID: 1384058
  39. Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal.
    Virology. 1992 Nov;191(1):237-45 PMID: 1413504
  40. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees.
    Virology. 1993 May;194(1):263-76 PMID: 8480422
  41. An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation.
    J Virol. 1993 Jun;67(6):3254-63 PMID: 7684464
  42. Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis.
    J Virol. 1993 Jul;67(7):3756-62 PMID: 8510204
  43. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.
    J Virol. 1994 Mar;68(3):1651-9 PMID: 8107226
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1998-08-00
Pages
6785-95
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC109887
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com